Published online before print October 25, 2007, doi: 10.1161/STROKEAHA.107.495770
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2007;38:3117.)
© 2007 American Heart Association, Inc.
Editorials |
Blood Vessels, Migraine, and Stroke
From the Stroke and Neurovascular Regulation Laboratory (M.A.M.), Department of Radiology Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass; The Divisions of Aging and Preventive Medicine (T.K.), Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; and the Department of Epidemiology (T.K.), Harvard School of Public Health, Boston, Mass.
Correspondence to Michael A. Moskowitz, MD, Stroke and Neurovascular Regulation Laboratory, Department of Radiology Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass CNY 149-6403. E-mail moskowitz{at}helix.mgh.harvard.edu
Key Words: genetics • migraine • risk factors • stroke
See related article, pages 3145–3151.
The relation between migraine and stroke has been well recognized and has been the focus of several publications.1–3 Despite many hypotheses linking the 2 disorders, the precise mechanisms are unknown, and not surprisingly very complex. In this issue of Stroke, Pezzini and colleagues4 add to this complexity by suggesting that migraine with aura may "mediate" the influence of specific genotypes on stroke risk. How might this interesting association come about biologically? At the present time, we don’t know. Investigators believe that migraine is a complex genetic disorder5 in which multiple genes confer a small migraine risk burden together with a large impact from environmental events such as stress. However, genes responsible for causing common migraine subtypes such as migraine with and without aura are unknown as of this writing; therefore, it remains obscure whether a genetic component is involved in the link between migraine and stroke, and hence the study by Pezzini and colleagues is of particular interest.
The methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism constitutes an interesting target to further evaluate the biological link between migraine and stroke. MTHFR catalyzes the conversion of 5,10 methylene tetrahydrofolate into 5-methyl-tetrahydrofolate, the predominant form of folate within blood. Folate is used in multiple biochemical pathways including replication of DNA, metabolism of homocysteine as well as other methyl transfer reactions. The MTHFR C677T gene polymorphism has been associated with migraine with aura in some6,7 but not all studies8,9 and is associated with an increase in homocysteine, a stroke risk factor causing endothelium dysfunction.10,11
Pezzini and colleagues investigate whether the MTHFR polymorphism and migraine independently lead to stroke or whether there is evidence that migraine mediates the association between this polymorphism and stroke. To evaluate these different associations in their data, the authors first test whether the polymorphism is associated with migraine among individuals without stroke and second, in a different study sample, whether the MTHFR polymorphism and migraine are associated with stroke risk. Statistical models can help to specify causal (ie, biological) relationships under specific assumptions. These assumptions include the absence of selection bias, use of appropriate control for potential confounding factors, as well as excluding the possibility of unmeasured confounders.12 However, although the data support (1) a link between the MTHFR polymorphism and both migraine with aura and ischemic stroke, and (2) an association between migraine with aura and ischemic stroke, future studies should directly observe whether the effect of the MTHFR polymorphism on ischemic stroke is mediated (ie, has different effect sizes) according to migraine aura status within the patient population. Pezzini and colleagues provide an important first step in suggesting an interrelationship between the MTHFR polymorphism, migraine with aura, and ischemic stroke. However, additional studies are now warranted to confirm these provocative findings and to clarify important points raised by this article.
Of course, an association between migraine headache and vascular dysfunction is not new. For example, the syndrome of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a vascular disorder that causes migraine headaches early in life, and stroke after age 30. Mutations in the notch-3 gene cause a diagnostic phenotype in vascular smooth muscle and a disturbance in cerebral blood flow regulation, at least in an animal experimental study.13 Precisely how this mutation causes stroke (not to mention migraine) remains unclear, but importantly, notch-3 appears to be expressed exclusively in vascular smooth muscle within adult brain. Both migraine with aura and CADASIL have been linked to significant changes in white matter. The lesion distribution within white matter is regionally distinct in CADASIL and usually greater in extent than in migraine with aura. Some studies suggest that migraineurs with aura also show a higher risk for cerebellar lesions that appear vascular in nature as they reportedly localize to watershed zones.14 Arteriovenous malformations and small angiomas sometimes cause attacks of migraine with aura, further linking blood vessel abnormalities to a migraine with aura phenotype.
More subtle mechanisms may be invoked to link typical forms of migraine and risk for stroke. For example, humans harboring mutations that disrupt the microcirculation and vascular regulation may be challenged by repeated events such as those accompanying migraine with aura. Cortical spreading depression (CSD) has been implicated as a key biological event causing aura and is characterized by intense, propagating depolarization of neurons and glia. During aura and CSD, hyperperfusion occurs early, whereas hypoperfusion often develops in a delayed fashion, and flow may be reduced in some patients by as much as 40% to 50%. Although a recent study suggested that functional arterial properties are altered in patients with migraine,15 the extent to which migraine or CSD reduces endothelium-dependent relaxation (eg, disturbed in hyperhomocytinemia possibly due to MTHFR C677T gene polymorphism), reduces blood flow or disrupts the microcirculation and its endothelial lining, and predisposes to stroke in a patient with migraine susceptibility remains to be solved. It has been well established that ischemia or hypoxia are particularly able to evoke CSD,16 and platelet stickiness has been implicated in migraine as well. It should also be noted that homocysteine in increasing amounts suppresses Na+-K+-ATPase activity in parietal, prefrontal, and cingulated cortex of rats, raising alternative possibilities for both migraine and stroke pathogenesis.17 Hence, the possibilities for this association extend beyond the cerebral blood vessel wall to possibly implicate neurons and glia as well.
The findings by Pezzini and colleagues are provocative and await confirmation. They do serve to remind us of the potential link between cerebral blood vessels and migraine with aura and its complex relationship to stroke and the neurovascular unit.
Acknowledgments
Disclosures
Dr Moskowitz is a member of the Neuroscience Advisory Board, AstraZeneca. Dr Kurth has received within the last 5 years investigator-initiated research funding from Bayer AG, McNeil Consumer & Specialty Pharmaceuticals, and Wyeth Consumer Healthcare, and he is a consultant to i3 Drug Safety.
Footnotes
The opinions in this editorial are not necessarily those of the editors or of the American Heart Association.
References
- Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005; 330: 63–65.
[Abstract/Free Full Text] - Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM, Diener HC, Buring JE. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology. 2005; 64: 1020–1026.
[Abstract/Free Full Text] - MacClellan LR, Giles WH, Cole J, Wozniak MA, Stern B, Mtichell B, Kittner SJ. Probable migraine with visual aura and risk of ischemic stroke: The Stroke Prevention In Young Women Study. Stroke. 2007; 38: 2438–2445.
[Abstract/Free Full Text] - Pezzini A, Grassi M, Del Zotto E, Giossi A, Monastero R, Della Volta G, Archetti S, Zavarise P, Camarda C, Gasparotti R, Magoni M, Cararda R, Padovani A. Migraine mediates the influence of C677T MTHFR genotype on ischemic stroke risk with a stroke subtype effect. Stroke. 2007; 38: 3145–3151.
[Abstract/Free Full Text] - van den Maagdenberg AM, Haan J, Terwindt GM, Ferrari MD. Migraine: gene mutations and functional consequences. Curr Opin Neurol. 2007; 20: 299–305.[Medline] [Order article via Infotrieve]
- Scher AI, Terwindt GM, Verschuren WM, Kruit MC, Blom HJ, Kowa H, Frants RR, van den Maagdenberg AM, van Buchem M, Ferrari MD, Launer LJ. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol. 2006; 59: 372–375.[CrossRef][Medline] [Order article via Infotrieve]
- Lea RA, Ovcaric M, Sundholm J, MacMillan J, Griffiths LR. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med. 2004; 2: 3.[CrossRef][Medline] [Order article via Infotrieve]
- Todt U, Freudenberg J, Goebel I, Netzer C, Heinze A, Heinze-Kuhn K, Gobel H, Kubisch C. MTHFR C677T polymorphism and migraine with aura. Ann Neurol. 2006; 60: 621–622; author reply 622–623.[Medline] [Order article via Infotrieve]
- Kaunisto MA, Kallela M, Hamalainen E, Kilpikari R, Havanka H, Harno H, Nissila M, Sako E, Ilmavirta M, Liukkonen J, Teirmaa H, Tornwall O, Jussila M, Terwilliger J, Farkkila M, Kaprio J, Palotie A, Wessman M. Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia. 2006; 26: 1462–1472.[CrossRef][Medline] [Order article via Infotrieve]
- Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet. 2005; 365: 224–232.[Medline] [Order article via Infotrieve]
- Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, Heistad DD, Faraci FM, Lentz SR. Endothelial dysfunction and elevation of s-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res. 2001; 88: 1203–1209.
[Abstract/Free Full Text] - Robins JM. Data, design, and background knowledge in etiologic inference. Epidemiology. 2001; 12: 313–320.[CrossRef][Medline] [Order article via Infotrieve]
- Lacombe P, Oligo C, Domenga V, Tournier-Lasserve E, Joutel A. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke. 2005; 36: 1053–1058.
[Abstract/Free Full Text] - Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Infarcts in the posterior circulation territory in migraine: The Population-Based MRI Camera Study. Brain. 2005; 128: 2068–2077.
[Abstract/Free Full Text] - Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology. 2007; 68: 1563–1570.
[Abstract/Free Full Text] - Takano T, Tian GF, Peng W, Lou N, Lovatt D, Hansen AJ, Kasischke KA, Nedergaard M. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 2007; 10: 754–762.[CrossRef][Medline] [Order article via Infotrieve]
- Matte C, Monteiro SC, Calcagnotto T, Bavaresco CS, Netto CA, Wyse AT. In vivo and in vitro effects of homocysteine on Na+, K+-atpase activity in parietal, prefrontal and cingulate cortex of young rats. Int J Dev Neurosci. 2004; 22: 185–190.[CrossRef][Medline] [Order article via Infotrieve]
Related Article:
- Migraine Mediates the Influence of C677T MTHFR Genotypes on Ischemic Stroke Risk With a Stroke-Subtype Effect
- Alessandro Pezzini, Mario Grassi, Elisabetta Del Zotto, Alessia Giossi, Roberto Monastero, Giorgio Dalla Volta, Silvana Archetti, Paola Zavarise, Cecilia Camarda, Roberto Gasparotti, Mauro Magoni, Rosolino Camarda, and Alessandro Padovani
Stroke 2007 38: 3145-3151.[Abstract] [Full Text] [PDF]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||